CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $26.47B, higher than 95% of all stocks globally
- PositionProfit margin is 21.4%, higher than 95% of its Diagnostics & Research peers (median 0.8%)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
26.47BUSDvs all stocks (USD)
Trailing P/E
30.77xvs Diagnostics & Research peers
Revenue (TTM)
4.09BUSDvs all stocks (USD)
Profit Margin
21.40%vs Diagnostics & Research peers
Beta
1.25xvs all stocks
52-Week Change
12.31%vs all stocks
Market Capitalization
26.47BUSDvs all stocks (USD)
Enterprise Value
28.64BUSDvs all stocks (USD)
Trailing P/E
30.77xvs Diagnostics & Research peers
Forward P/E
25.55xvs Diagnostics & Research peers
PEG Ratio
4.73xPrice to Sales (TTM)
6.47xvs Diagnostics & Research peers
Enterprise to Revenue
7.00xvs Diagnostics & Research peers
Enterprise to EBITDA
23.52xvs Diagnostics & Research peers
Gross Margin
58.68%vs Diagnostics & Research peers
Profit Margin
21.40%vs Diagnostics & Research peers
Operating Margin
23.29%vs Diagnostics & Research peers
Return on Assets (TTM)
20.57%vs Diagnostics & Research peers
Revenue (TTM)
4.09BUSDvs all stocks (USD)
Revenue per Share (TTM)
199.85USDUpdated Jul 19, 2026Quarterly Revenue Growth
7.20%vs Diagnostics & Research peers
Gross Profit (TTM)
2.42BUSDvs all stocks (USD)
EBITDA (TTM)
1.28BUSDvs all stocks (USD)
Net Income (TTM)
875.06MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
3.60%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
901.12MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
615.04MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
4.03BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.64BUSDFY2025 · Dec 31, 2025Gross Profit
2.39BUSDFY2025 · Dec 31, 2025Operating Income
1.12BUSDvs all stocks (USD)
Pre-tax Income
1.05BUSDFY2025 · Dec 31, 2025Income Tax Expense
179.72MUSDFY2025 · Dec 31, 2025Net Income
869.19MUSDFY2025 · Dec 31, 2025EBIT
1.12BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.26BUSDFY2025 · Dec 31, 2025Research & Development
199.37MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
998.31MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
68.52MUSDFY2025 · Dec 31, 2025EPS (Basic)
42.17USDFY2025 · Dec 31, 2025EPS (Diluted)
42.05USDFY2025 · Dec 31, 2025Basic Shares Outstanding
20.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
20.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
869.19MUSDFY2025 · Dec 31, 2025Operating Cash Flow
990.02MUSDFY2025 · Dec 31, 2025Free Cash Flow
882.89MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
66.89MUSDFY2025 · Dec 31, 2025Income Tax Paid
180.85MUSDFY2025 · Dec 31, 2025Interest Paid
66.63MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
869.19MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
125.61MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
3.79MUSDFY2025 · Dec 31, 2025Stock-based Compensation
22.51MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-46.35MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
33.76MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.50MUSDFY2025 · Dec 31, 2025Capital Expenditures
-107.12MUSDFY2025 · Dec 31, 2025Net Acquisitions
-93.84MUSDFY2025 · Dec 31, 2025Other Investing Activity
7.09MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-193.87MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
2.00BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.97BUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-800.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-8.91MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-787.45MUSDFY2025 · Dec 31, 2025Shares Outstanding
20.21MSharesUpdated Jul 19, 2026Float Shares
20.10MSharesUpdated Jul 19, 2026Shares Short
736.33KSharesUpdated Jul 19, 2026Short Ratio
3.15daysvs all stocks
Short % of Shares Outstanding
4.18%vs all stocks
% Held by Insiders
0.43%vs all stocks
% Held by Institutions
103.46%vs all stocks
Total Cash (MRQ)
60.57MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.00USDUpdated Jul 19, 2026Total Debt (MRQ)
2.23BUSDvs all stocks (USD)
Current Ratio (MRQ)
1.20xvs Diagnostics & Research peers
Book Value per Share (MRQ)
-2.07USDUpdated Jul 19, 2026Total Assets
3.71BUSDvs all stocks (USD)
Total Current Assets
1.36BUSDFY2025 · Dec 31, 2025Total Liabilities
3.74BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.35BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.54BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.20BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
66.89MUSDFY2025 · Dec 31, 2025Accounts Receivable
778.24MUSDFY2025 · Dec 31, 2025Inventory
387.23MUSDFY2025 · Dec 31, 2025Accounts Payable
266.63MUSDFY2025 · Dec 31, 2025Short-term Debt
63.93MUSDFY2025 · Dec 31, 2025Deferred Revenue
229.38MUSDFY2025 · Dec 31, 2025Long-term Debt
2.09BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
298.14MUSDFY2025 · Dec 31, 2025Common Stock (Book)
448.00KUSDFY2025 · Dec 31, 2025Retained Earnings
9.24BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-23.64MUSDvs all stocks (USD)
Treasury Stock
9.84BUSDFY2025 · Dec 31, 202552-Week Low
1.02KUSDUpdated Jul 19, 202652-Week High
1.53KUSDUpdated Jul 19, 202652-Week Change
12.31%vs all stocks
Beta
1.25xvs all stocks
50-Day MA
1.19KUSDUpdated Jul 19, 2026200-Day MA
1.32KUSDUpdated Jul 19, 2026Avg 10-Day Volume
135.00KSharesUpdated Jul 19, 2026Avg 30-Day Volume
202.97KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
42.58USDUpdated Jul 19, 2026Other Income / Expense
-1.07MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 21.4%, higher than 95% of its Diagnostics & Research peers (median 0.8%)Significant
Profit margin: 0.21Industry median: 0.01Industry P95: 0.21Peers compared: 31.00
Financial Health
Altman Z-Score 9.86: safe zoneNotable
Altman Z-Score: 9.86
High earnings qualityNotable
Earnings Quality Score: 0.69
High structural barrier to entryNotable
Barrier to Entry: 0.65
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $26.47B, higher than 95% of all stocks globallySignificant
Market cap (USD): 26,472,361,866Global P95: 25,614,208,870.135
Revenue is $4.09B, above the global median of $520.53MNotable
Revenue (USD): 4,089,782,016Global Median: 520,528,949.311
Levered free cash flow is $615.04M, above the global median of $16.24MNotable
Levered free cash flow (USD): 615,044,352Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Asian Paints Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CRRC Corporation Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ørsted A/S
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Huaneng Lancang River Hydropower Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hangzhou Chang Chuan Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
PPG Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
dsm-firmenich AG
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Hubbell Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Ningxia Baofeng Energy Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Amrize Ltd
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Harmony Biosciences Holdings, Inc.
2 interpretationsCash-Flow Ratios ElevatedThree Asset-Base Ratios Elevated
CarGurus, Inc.
2 interpretationsCash-Flow Ratios ElevatedThree Asset-Base Ratios Elevated
The Toro Company
2 interpretationsLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated